Search

FreeStyle Lingo

FDA Clearance Received June 2024, Currently Unavailable 

Abbott’s Lingo CGM was designed for people 18 and older to better understand and improve their general health and wellness. Lingo tracks glucose and provides personalized insights and customized coaching to help people create healthy habits, retrain their metabolism, and improve their overall well-being. 

Lingo was not created to diagnose diseases or to be used by people with diabetes. 

No prescription is required for the Libre Lingo. 

For complete information, visit Hello Lingo

Sensor Duration:
Up to 14 days
Approved For Children:
18 years and over
Fingerstick Calibration Required:
Yes. Day 1: 1st calibration required: 2 hours after Guardian™ Sensor 3 and Guardian™ Connect Transmitter have been connected. 2nd calibration required: within 6 hours of the first calibration. Days 2-7:Every 12 hours and as requested by the system.
Customizable Alerts Alarms:
None
Covered By Medicare:
No
Insulin Pump Compatibility:
No
Recommended Placement:
Back of upper arm

Additional Details:
Abbott Lingo is for use by people who are looking to identify foods and habits that work for their body, routine, and metabolism. It is not for people with diabetes. 

Continuous Data Transmission:
Lingo streams data to the users smartphone

Danatech resources available upon release

    Manufacturer Resources available upon release

    Visit  Hello Lingo to sign up to be notified as soon as Lingo is available.

     

     

    In a randomized controlled trial, participants were divided into two groups. Both groups were told to exercise and follow a low-glycemic index diet. The only difference? One group got a CGM, enabling them to monitor their response to food throughout the trial. After two months, the CGM group had lost more weight, more body fat, and had better cholesterol and fasting glucose — all key markers of improved metabolic health.

    Source: Chekima K, Noor MI, Ooi YBH, Yan SW, Jaweed M, Chekima B. Utilising a Real-Time Continuous Glucose Monitor as Part of a Low Glycaemic Index and Load Diet and Determining Its Effect on Improving Dietary Intake, Body Composition and Metabolic Parameters of Overweight and Obese Young Adults: A Randomised Controlled Trial. Foods. 2022;11(12):1754. Published 2022 Jun 15. doi:10.3390/foods11121754. https://pubmed.ncbi.nlm.nih.gov/35741952/


    The Danatech Digest

    Join 18,000+ professionals who get our latest diabetes technology updates

        

    DISCLAIMERS:

    This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

    ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.


    Our Sponsors